Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 34
Selected: 0
NCT IDTitle
NCT04947553A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
NCT06170970Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
NCT06360419Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
NCT02504008CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
NCT04019704A Trial of AXS-05 in Patients With Major Depressive Disorder
NCT06878976Open-Label Safety Study of Solriamfetol in Subjects with Binge Eating Disorder
NCT03595579Assessing Symptomatic Clinical Episodes in Depression
NCT05008341Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
NCT02741791A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
NCT05113745A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects with Narcolepsy (ENCORE)
NCT06736509An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
NCT05557409A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation
NCT02746068A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
NCT06223880A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
NCT03226522Addressing Dementia Via Agitation-Centered Evaluation
NCT04788953Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder
NCT04634669Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
NCT03896009Maximizing Outcomes in Treating Acute Migraine
NCT06568367Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
NCT04068051Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)
NCT04971291An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients
NCT05059223A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
NCT06413433Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
NCT05550207Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
NCT06413420SUNOSI® (Solriamfetol) Pregnancy Registry
NCT05972044A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
NCT04789174Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
NCT05838430Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT04163185Initiating Early Control of Migraine Pain and Associated Symptoms
NCT03881852Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)
NCT04797715Assessing Clinical Outcomes in Alzheimer's Disease Agitation
NCT04039022Open-Label Safety Study of AXS-05 in Subjects With Depression
NCT04608396Mechanistic Evaluation of Response in TRD (MERIT)
NCT03471767AXS-05 Phase II Trial on Smoking Behavior